Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology. (Q38939078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

review article

1 reference

title

Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Adamasco Cupisti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Domenico Santoro

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Roberto Minutolo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Vincenzo Bellizzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Giuseppe Conte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Luca De Nicola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Biagio R Di Iorio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Gianfranca Cabiddu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Marcora Mandreoli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Ernesto Paoletti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Giorgina B Piccoli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Giuseppe Quintaliani

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Maura Ravera

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Serena Torraca

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

“Conservative Treatment of CKD” Study Group of the Italian Society of Nephrology

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

1 reference

27 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

published in

Journal of Nephrology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

159-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40620-016-0338-x

21 March 2020

exact match

0 references

cites work

US Renal Data System 2012 Annual Data Report

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Updating the natural history of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

The modern spectrum of renal biopsy findings in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal involvement: a single centre review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Clinical predictors of non-diabetic renal disease in patients with non-insulin dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Clinical challenges in diagnosis and management of diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

New therapeutic strategies under development to halt the progression of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Renal lesions in patients with type 2 diabetes: a puzzle waiting to be solved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Combined angiotensin inhibition for the treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Role of remission clinics in the longitudinal treatment of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Improving the efficacy of RAAS blockade in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Cigarette Smoking and Chronic Kidney Disease in African Americans in the Jackson Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

The prevalence of anemia in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Parenteral versus oral iron therapy for adults and children with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Tolerability of different oral iron supplements: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Protein intake and kidney function in the middle-age population: contrast between cross-sectional and longitudinal data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Prognosis of CKD patients receiving outpatient nephrology care in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

"Dietaly": practical issues for the nutritional management of CKD patients in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Diets for patients with chronic kidney disease, still worth prescribing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Dietary protein restriction for renal patients: don't forget protein-free foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Economic effects of treatment of chronic kidney disease with low-protein diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Early changes in bioelectrical estimates of body composition in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

A randomized trial of dietary sodium restriction in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Sodium intake, ACE inhibition, and progression to ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Achievement of target blood pressure levels in chronic kidney disease: a salty question?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Effect of bicarbonate supplementation on renal function and nutritional indices in predialysis advanced chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Bicarbonate supplementation slows progression of CKD and improves nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Should chronic metabolic acidosis be treated in older people with chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Incident cardiovascular disease events in metabolically benign obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Obesity management in adults with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Weight loss in obese patients with chronic kidney disease: who and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

The impact of renal function on outcomes of bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Worldwide access to treatment for end-stage kidney disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Timing of Initiation of RRT and Modality Selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

High cardiovascular event rates occur within the first weeks of starting hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Epidemiology of CKD Regression in Patients under Nephrology Care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Estimating the financial cost of chronic kidney disease to the NHS in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Incremental haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0338-X

A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases

21 January 2018

1 reference

12 December 2020

Chapter 3: Management of progression and complications of CKD

1 reference

12 December 2020

Initiation of dialysis: Trigger or cause of cardiovascular events?

1 reference

12 December 2020

[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease].

1 reference

12 December 2020

Compliance with protein restriction: effects on metabolic acidosis and progression of renal failure in chronic uremics on supplemented diet

1 reference

12 December 2020

Incremental peritoneal dialysis: effects on the choice of dialysis modality, residual renal function and adequacy

1 reference

12 December 2020

Low protein diets for chronic kidney disease in non diabetic adults

1 reference

12 December 2020

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

12 December 2020

Approach to the Treatment of Chronic Metabolic Acidosis in CKD.

1 reference

12 December 2020

Urinary Sodium and Potassium Excretion and CKD Progression

1 reference

12 December 2020

Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study

1 reference

12 December 2020

An autopsy study suggests that diabetic nephropathy is underdiagnosed.

1 reference

12 December 2020

Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes?

1 reference

12 December 2020

Dietary sodium and blood pressure: interactions with other nutrients

1 reference

12 December 2020

Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers

1 reference

12 December 2020

Optimal intakes of protein in the human diet

1 reference

12 December 2020

Reversibility of the “Salt-Losing” Tendency of Chronic Renal Failure

1 reference

12 December 2020

Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation

1 reference

12 December 2020

NaHCO3 and NaCl tolerance in chronic renal failure II

1 reference

12 December 2020

Keto acid therapy in predialysis chronic kidney disease patients: final consensus

1 reference

12 December 2020

Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease

1 reference

12 December 2020

10.1007/S40620-016-0338-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27568307%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 March 2020

1010486632

0 references

Fatcat ID

release_3li2bxi2trhdroi6wp3fjkwrya

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3li2bxi2trhdroi6wp3fjkwrya

24 November 2022

mapped directly with Wikidata item

1 reference